![ASCO 2022 Conference Coverage](http://media.vumedi.com/thumbs/channel_logo/2022/5/eadfa937-de35-4504-be38-58654669525f.png.200x0_q85.png)
ASCO 2022 Conference Coverage
Playback speed
10 seconds
Lecture Summary - ASCO 2022 on a Randomized Phase II/III PARTNER Trial to Evaluate the Safety & Efficacy of the Addition of Olaparib to Platinum-based Neoadjuvant Chemo in TNBC and/or Germline BRCAm BC
By
ASCO 2022 Conference Coverage
FEATURING
Rebecca Lucey
By
ASCO 2022 Conference Coverage
FEATURING
Rebecca Lucey
10 views
June 16, 2022
Login to view comments.
Click here to Login
Breast